임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 1상상태 미확인· Erosive Gastroesophageal Reflux Diseaseto Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection
리드: 대웅제약
- 3상상태 미확인· T2DM (Type 2 Diabetes Mellitus)Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers
리드: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers
리드: 대웅제약
- 1상상태 미확인· Drug Drug InteractionDrug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
리드: 대웅제약
- 3상상태 미확인· Non-erosive Reflux DiseaseStudy to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)
리드: 대웅제약
- 2상상태 미확인· OsteoarthritisEfficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients
협력: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers
리드: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers
리드: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers
리드: 대웅제약
- 1상상태 미확인· Diabetes Mellitus, Type 2To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function
리드: 대웅제약
- 3상상태 미확인· Type 2 Diabetes MellitusA Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 1상상태 미확인· Phase 1 Study, Healthy VolunteersA Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects
리드: 대웅제약
- 1상상태 미확인· Drug-drug InteractionDrug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects
리드: 대웅제약
- 1상상태 미확인· Drug Drug InteractionPhase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
리드: 대웅제약
- 3상상태 미확인· Diabetes MellitusThe Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
리드: 대웅제약
- 해당없음상태 미확인· Gestational Diabetes Mellitus in PregnancyLong-term Effects of Flash Glucose Monitoring System in Patients With Gestational Diabetes
협력: 대웅제약
- 4상상태 미확인· Alzheimer DiseaseEfficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
리드: 대웅제약
- 1상상태 미확인· Healthy VolunteersThe Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults
리드: 대웅제약
- 해당없음상태 미확인· Erosive EsophagitisTreatment Effect According to Timing of Administration of DWP14012 40 mg
협력: 대웅제약
- 해당없음상태 미확인· Erosive EsophagitisTreatment Effect According to Timing of Administration of DWP14012 40 mg
리드: 대웅제약
- 1상상태 미확인· COVID-19 PatientsTo Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003
리드: 대웅제약
- 3상상태 미확인· Healed Erosive EsophagitisStudy to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis
리드: 대웅제약
- 1상상태 미확인· Healthy Male VolunteersDrug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs
리드: 대웅제약
- 3상상태 미확인· Hypertension, DyslipidemiaClinical Trail to Evaluate the Efficacy and Safety of DWJ1451
리드: 대웅제약
- 2상상태 미확인· T2DM (Type 2 Diabetes Mellitus)Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 1상상태 미확인· HealthyPharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers
리드: 대웅제약
- 3상상태 미확인· Non-Erosive Gastroesophageal Reflux DiseaseStudy to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease
리드: 대웅제약
- 2상상태 미확인· Benign Masseteric HypertrophyDWP450 Treatment in Subjects With Benign Masseteric Hypertrophy
리드: 대웅제약
- 3상상태 미확인· Crow's Feet LinesEfficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)
리드: 대웅제약
- 1상상태 미확인· HealthyPharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers
리드: 대웅제약
- 4상상태 미확인· Spasticity as Sequela of StrokeDose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity
협력: 대웅제약
- 2/3상상태 미확인· Crows Feet LinesEfficacy and Safety of DWP450 for the Treatment of Crows Feet Lines
리드: 대웅제약
- 3상상태 미확인· Patients With Thyroidecomy (Scheduled)Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy
리드: 대웅제약
- 단계 미표기상태 미확인· MCA - Middle Cerebral Artery DissectionPrescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease
리드: 대웅제약
- 2상상태 미확인· Hepatitis; Virus, Chronic, Type BA Clinical Trials to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With HBV
협력: 대웅제약
- 3상상태 미확인· HypertensionEffect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension
협력: 대웅제약
- 단계 미표기상태 미확인· CT Scanning PatientsObservational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients
리드: 대웅제약
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.